A randomized controlled clinical research to evaluate the pregnancy rate in one year and safety of traditional Chinese medicine multi-channel therapy after laparoscopy for refractory tubal infertility

Fujian Nanping people's Hospital0 个研究点开始时间: 待定最近更新: 2023年2月20日

适应症

试验速览

暂无简介。

•? Consistent with the diagnosis of refractory infertility;
•? Infertility in line with tubal factors and at least one fallopian tube is unobstructed after hysteroscopy;
•? Aged 23-40 years, the man's semen examination was normal;
•? Informed consent and willingness to cooperate.

•? Infertility combined with other factors;
•? Heart, liver, kidney and other important organ diseases;
•? Those who are unable to cooperate due to neurological and mental disorders;
•? Those who are allergic to the therapeutic drugs of this study (such as Salvia miltiorrhiza powder injection, amikacin, moxa, etc.) or have clear treatment contraindications;
•? Those who refuse treatment and refuse to sign informed consent.

发起方

Fujian Nanping people's Hospital